AndhraNews.net
Home » International News / Press Releases » March 15, 2017 » Painless Non-surgical Hemorrhoidal Treatment Available in Hong Kong

Painless Non-surgical Hemorrhoidal Treatment Available in Hong Kong


HONG KONG, March 15, 2017 /PRNewswire/ -- Dragon Jade International Limited today announced it offers a safe, non-surgical electrotherapy treatment for hemorrhoidal disease at the company's clinic in Hong Kong.   

The procedure, which has been used by doctors to treat over 160,000 hemorrhoid patients across the globe, is a quick, effective and painless alternative to hemorrhoid surgery and other treatment modalities for hemorrhoid disease. During the electrotherapy process, a tiny electrical current is applied to the base of hemorrhoid, causing a biochemical reaction breaking down water molecules and creating a high alkaline environment within the hemorrhoid's vascular feeding vessels. This in turn produces a chemical cauterization within these vessels that dissolves the hemorrhoid, which is harmlessly reabsorbed into the body. 

Within about 30 minutes, patients typically experience substantial pain relief and can usually resume normal activities shortly afterwards. And, since the procedure is non-invasive and does not require anesthetic, it is safe for nearly all patients including the elderly, postpartum women and patients who have had this or other hemorrhoidal procedures in the past. (The use of electrical current in the treatment may make the procedure inappropriate for patients who are pregnant, wear a pacemaker and/or defibrillator implant, or have a bleeding disorder.)

The procedure is cleared by the Food and Drug Administration (FDA) in the U.S. and the National Institutes for Health and Care Excellence (NICE) in the U.K.  

Hemorrhoids -- bundles of veins in the rectum and/or anus that have swelled up and become enlarged and painful -- are a very common disease and affect both men and women from pre-teen to the aged. According the Hospital Authority Statistical Report 2014-2015, approximately 24,000 people treated in Hong Kong's hospitals were affected by hemorrhoids1.  According to U.S National Institutes of Health, 75% of the world population are affected by hemorrhoids at some point during their lives2. Most traditional hemorrhoidal treatments, however, are largely invasive, resulting in severe pain and sometimes requiring long periods for recovery. Moreover, patients who opt for these treatments but who subsequently experience recurrences of their hemorrhoids often do not respond to additional treatments.  

Surgical hemorrhoid treatments such as hemorrhoidectomy and stapled hemorrhoidectomy usually require patients to remain in the hospital many days for recovery. Rubber band ligation, which is performed on an outpatient basis, causes little pain but has a relatively high hemorrhoid recurrence rate. Non-prescription topical medications are available for hemorrhoids, but are widely considered the least effective of treatments for this condition. 

The electrotherapy hemorrhoid procedure, however, is considered highly effective, is non-invasive, has virtually no recovery time, and has proven virtually free of complications.

For further information on the procedure, patients may contact Dr. Steve Lai at dr.lai@uamedicalnet.com.

Treatments comparison table

Procedure

Applicability

Treatment Time

Recovery Time

Major Advantages

Risk

Recurrence Rate

Electrotherapy

Hemorrhoidal  Procedure

All Grades

~ 20- 30 mins

Resume normal activities immediately following the treatment

10 minute procedure, with no report of complications

Low

>20%

Hemorrhoidectomy

Grade 3 and 4

~ 45mins

Requires a hospital stay with at least 1 week to recover

Permanent removal, low recurrence rate

Complications; Bleeding, severe pain, risks of infection

>10%

Stapled Hemorrhoidectomy

Grade 1 and 3

~ 45mins

Requires a hospital stay with at least 1 week to recover

 

High reimbursement

 

 

Complications; severe pain, bleeding, risks of infection  

>10%

Rubber Band Ligation

Grade 1 and 2

~ 5mins

Performed in clinic, with a few hours to recover and rest

Low cost, easy to perform

Severe pain, urinary retention, high recurrence and risks of infection

50%

Medication

Grade 1 and 2

N/A

N/A

Temporary relief

Masks problem with no solution

High

About Dragon Jade 

Dragon Jade International Limited and its subsidiaries ("the Group") is focused on identifying, developing and marketing the next generation of herbal and natural products that improve people's lives. The Group is positioned to leverage proven resources that allow us to assess, enhance and realize the commercial potential of herbal and biotechnological discoveries. The Group strives to develop and offer to the market the broadest selection of cost-effective healthy living products, which shall deliver substantial returns to investors. More information on Dragon Jade, visit the Company's website: http://www.dgjigroup.com

References

[1] Hospital Authority Statistical Report (2014-2015). Hospital Authority. URL:
http://www.ha.org.hk/haho/ho/stat/HASR1415_2.pdf. Accessed on Feb 2017.

2 |National Institute of Diabetes and Digestive and Kidney Diseases. U.S. Department of Health and Human Services. URL: http://www.niddk.nih.gov/health-information/health-topics/digestive-diseases/hemorrhoids/Pages/facts.aspx. Accessed on 13 Feb 2017.

Safe Harbor Statement

This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as the Company "believes," "expects," "anticipates," "foresees," "estimates," or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions, or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Contact:
Corporate Relations Department
Dragon Jade International
info@dgjigroup.com
(852) 2695-6999

Comment on this story

Share